Page last updated: 2024-08-21

dihydrotestosterone and Blood Loss, Surgical

dihydrotestosterone has been researched along with Blood Loss, Surgical in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Antonini, G; Busetto, GM; De Berardinis, E; Del Giudice, F; Gentile, V; Giovannone, R; Ragonesi, G; Rossi, A; Tricarico, S	1

Trials

1 trial(s) available for dihydrotestosterone and Blood Loss, Surgical

Article	Year
Short-term pretreatment with a dual 5α-reductase inhibitor before bipolar transurethral resection of the prostate (B-TURP): evaluation of prostate vascularity and decreased surgical blood loss in large prostates. BJU international, 2015, Volume: 116, Issue:1 Topics: 5-alpha Reductase Inhibitors; Aged; Aged, 80 and over; Azasteroids; Biomarkers; Blood Loss, Surgical; Dihydrotestosterone; Dutasteride; Humans; Male; Middle Aged; Postoperative Complications; Prostate; Prostate-Specific Antigen; Testosterone; Transurethral Resection of Prostate; Treatment Outcome	2015

Article

Year

Short-term pretreatment with a dual 5α-reductase inhibitor before bipolar transurethral resection of the prostate (B-TURP): evaluation of prostate vascularity and decreased surgical blood loss in large prostates.

BJU international, 2015, Volume: 116, Issue:1

Topics: 5-alpha Reductase Inhibitors; Aged; Aged, 80 and over; Azasteroids; Biomarkers; Blood Loss, Surgical; Dihydrotestosterone; Dutasteride; Humans; Male; Middle Aged; Postoperative Complications; Prostate; Prostate-Specific Antigen; Testosterone; Transurethral Resection of Prostate; Treatment Outcome

2015